FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Regulation

Background:

• FoxO1, a transcription factor in osteoblasts, negatively impacts beta-cell function and insulin sensitivity.
• Osteocalcin, an osteoblast hormone, promotes glucose metabolism, and its activity is suppressed by FoxO1.
• ATF4 also influences glucose metabolism via osteoblast expression, prompting investigation into its interaction with FoxO1.

Purpose of the Study:

• To investigate the interaction between FoxO1 and ATF4 in osteoblasts.
• To elucidate the mechanisms by which FoxO1 and ATF4 regulate glucose homeostasis.
• To understand the downstream effects of this interaction on insulin production and sensitivity.

Main Methods:

• Co-localization studies to assess nuclear presence of FoxO1 and ATF4 in osteoblasts.
• Co-immunoprecipitation to confirm physical interaction between FoxO1 and ATF4.
• Genetic experiments to evaluate the combined effects of FoxO1 and ATF4 on glucose metabolism and osteocalcin activity.

Main Results:

• FoxO1 and ATF4 co-localize and physically interact within the osteoblast nucleus.
• The FoxO1-ATF4 complex promotes ATF4 transcriptional activity.
• Cooperative action of FoxO1 and ATF4 suppresses osteocalcin activity by upregulating its inactivating phosphatase, leading to increased glucose levels and impaired glucose tolerance.
• Compromised insulin production and signaling, along with increased fat weight, were observed.

Conclusions:

• FoxO1 and ATF4 cooperate within osteoblasts to regulate glucose homeostasis.
• This cooperation negatively impacts beta-cell function and insulin sensitivity.
• The FoxO1-ATF4 axis in osteoblasts represents a novel target for metabolic regulation.